Shams G, Harrold M W, Grazyl B, Miller D D, Feller D R
Division of Pharmacology, College of Pharmacy, Ohio State University, Columbus 43210.
Eur J Pharmacol. 1990 Aug 10;184(2-3):251-6. doi: 10.1016/0014-2999(90)90616-e.
The beta 1- and beta 2-adrenoceptor agonist properties of trimetoquinol (TMQ, I) and N-benzyl ring substituted TMQ analogues (II, 4'-methylbenzylTMQ; III, 4'-chloro-benzylTMQ; IV, 4'-methoxybenzylTMQ; V, 4'-nitrobenzylTMQ; VI, 3',4'-dichlorobenzylTMQ; and VII, 4'-aminobenzylTMQ) were studied in guinea pig atria and trachea. All compounds gave concentration-dependent responses in atria and trachea, and the rank order of beta-adrenoceptor agonist potency was I greater than VII greater than II greater than V greater than IV greater than VI greater than III and I greater than VII greater than IV = VI greater than V greater than III greater than II, respectively. Whereas the N-benzyl substitution reduced potency for beta-agonist activity, the beta 2/beta 1-selectivity ratio was enhanced by addition of groups to the N-benzyl ring, and the rank order of beta 2-selectivity was VI (10-fold) greater than III (8-fold) = IV (8-fold) greater than VII (3-fold) greater than V = I greater than II. The results show that varying the nature of substituents on the N-benzyl ring of TMQ produces compounds which retain greater beta 2-selectivity.
在豚鼠心房和气管中研究了曲美托喹(TMQ,I)及N-苄基环取代的TMQ类似物(II,4'-甲基苄基TMQ;III,4'-氯苄基TMQ;IV,4'-甲氧基苄基TMQ;V,4'-硝基苄基TMQ;VI,3',4'-二氯苄基TMQ;VII,4'-氨基苄基TMQ)的β1-和β2-肾上腺素能受体激动剂特性。所有化合物在心房和气管中均呈现浓度依赖性反应,β-肾上腺素能受体激动剂效力的排序分别为I>VII>II>V>IV>VI>III以及I>VII>IV = VI>V>III>II。虽然N-苄基取代降低了β-激动剂活性的效力,但通过在N-苄基环上添加基团提高了β2/β1选择性比值,β2选择性的排序为VI(10倍)>III(8倍) = IV(8倍)>VII(3倍)>V = I>II。结果表明,改变TMQ的N-苄基环上取代基的性质可产生具有更高β2选择性的化合物。